Our research supplements the function of hBD1 in anti-tuberculosis immunity and elucidates the regulatory mechanism of hBD1 expression in Mtb-infected AEC-II cells, providing a basis for the development of novel immunotherapies against tuberculosis and offering new insights for the treatment of drug-resistant tuberculosis. The gene discussed is DEFB1; the disease is tuberculosis.